Company Filing History:
Years Active: 2021-2024
Title: Ofra Levy-Hacham: Innovator in Rosacea Treatment
Introduction
Ofra Levy-Hacham is a notable inventor based in Ness Ziona, Israel. She has made significant contributions to the field of dermatology, particularly in the treatment of rosacea. With a total of five patents to her name, her work focuses on innovative methods to enhance therapeutic outcomes for patients.
Latest Patents
Ofra's latest patents include a method for providing early onset of action in the treatment of rosacea. This regimen involves topically applying a pharmaceutical composition containing 1% to 10% benzoyl peroxide as the sole active ingredient. The composition is designed to be applied once daily for a minimum of two weeks, aiming for a primary success measure of at least 9% improvement in the Investigator Global Assessment (IGA) scale. Another significant patent addresses the treatment of rosacea in patients aged 65 years and older, utilizing a similar composition to achieve a success rate of at least 15% in achieving clear or almost clear skin.
Career Highlights
Ofra Levy-Hacham is currently associated with Sol-Gel Technologies Ltd., where she continues to develop and refine her innovative treatments. Her work has been instrumental in advancing therapeutic options for individuals suffering from rosacea, particularly among older populations.
Collaborations
Ofra collaborates with notable colleagues, including Ofer Toledano and Ori Nov. Their combined expertise contributes to the ongoing research and development efforts at Sol-Gel Technologies Ltd.
Conclusion
Ofra Levy-Hacham's contributions to the treatment of rosacea exemplify her commitment to innovation in dermatology. Her patents reflect a deep understanding of patient needs and a dedication to improving skin health outcomes.